Monograph Details
|
|
Respiratory Tract
> Rhinitis/rhinorrhea (intranasal products)
|
|
OMNARIS |
| Manufacturer |
|
Sepracor, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Steroid. |
| Generic Name |
|
Ciclesonide 50micrograms/spray; aqueous nasal spray. |
| Indications |
|
Treatment of seasonal allergic rhinitis in patients ≥6yrs old and perennial allergic rhinitis in patients ≥12yrs old. |
| Children |
|
Seasonal allergic rhinitis: <6yrs: not recommended. ≥6yrs: 2 sprays in each nostril once daily (200mcg/day). |
| Adults |
|
2 sprays in each nostril once daily (200mcg/day). |
| Precautions |
|
Respiratory tract tuberculosis. Infections (eg, ocular herpes simplex). Unhealed nasal wounds. If adrenal suppression exists following systemic corticosteroid therapy, replacement with topical steroids may exacerbate symptoms of adrenal insufficiency. If exposed to measles or chickenpox, consider immunoglobulin prophylactic therapy. Reevaluate if no improvement after 2 weeks (for seasonal allergic rhinitis) and 5 weeks (for perennial allergic rhinitis). Monitor for growth suppression in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually), and for candida infection and other nasal mucosal changes. Monitor for vision changes or if history of glaucoma or cataracts. Avoid eyes. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
May be potentiated by ketoconazole. |
| Adverse Reactions |
|
Headache, epistaxis, nasopharyngitis, ear pain. |
| How Supplied |
|
Nasal spray (pump)—12.5g (120 sprays) |
|
|
|
|
